Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,760 | 6,630 | 2,740 | 3,450 | 8,180 |
| Marketable Securities | 53,074 | 400 | 6,410 | 21,030 | 23,160 |
| Receivables | 1,679 | 6,200 | 5,460 | 7,760 | 7,480 |
| Inventories | 6,729 | 3,760 | 1,520 | 1,670 | 860 |
| Other current assets | 6,662 | 16,630 | 8,950 | 2,740 | 5,680 |
| TOTAL | $112,322 | $33,620 | $25,080 | $36,650 | $45,360 |
| Non-Current Assets | |||||
| PPE Net | 1,776 | 17,430 | 18,230 | 19,380 | 21,420 |
| Intangibles | 46,880 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 13,227 | 65,190 | 73,980 | 13,360 | 7,820 |
| TOTAL | $61,883 | $82,620 | $92,210 | $32,740 | $29,240 |
| Total Assets | $174,205 | $116,250 | $117,310 | $69,400 | $74,610 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,440 | 19,190 | 3,350 | 2,020 | 2,310 |
| Accounts payable and accrued liabilities | 8,024 | 5,090 | 3,590 | 3,920 | 4,940 |
| Accrued Expenses | 5,667 | 6,520 | 5,010 | 5,470 | 6,000 |
| Other current liabilities | 45,732 | 9,690 | 2,320 | 6,790 | 6,100 |
| TOTAL | $70,842 | $40,590 | $14,350 | $18,310 | $19,420 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,277 | 66,320 | 33,270 | 1,680 | 1,540 |
| Deferred Revenues | 1,336 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 77,191 | 15,940 | 24,680 | 17,820 | 13,960 |
| TOTAL | $78,468 | $85,160 | $72,430 | $21,280 | $18,870 |
| Total Liabilities | $149,310 | $125,760 | $86,800 | $39,600 | $38,300 |
| Shareholders' Equity | |||||
| Common Shares | 6,188 | 3,740 | 3,710 | 3,640 | 3,580 |
| Retained earnings | -320,452 | -235,540 | -192,620 | -189,390 | -180,610 |
| Other shareholders' equity | -7,423 | 10,820 | 10,260 | 10,060 | 10,870 |
| TOTAL | $24,895 | $-9,510 | $30,500 | $29,790 | $36,300 |
| Total Liabilities And Equity | $174,205 | $116,250 | $117,300 | $69,390 | $74,600 |